TrialGut2009

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial.

W Kruis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.